![Frederick John Livesey](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Frederick John Livesey
Founder at Talisman Therapeutics Ltd.
Frederick John Livesey active positions
Companies | Position | Start | End |
---|---|---|---|
Talisman Therapeutics Ltd.
![]() Talisman Therapeutics Ltd. BiotechnologyHealth Technology Talisman Therapeutics Ltd. is a human stem cell research and development company. The firm is committed for revolutionizing the discovery of treatments for Alzheimer’s disease. The company is headquartered in Cambridge, the United Kingdom. | Director/Board Member | - | - |
Founder | - | - |
Career history of Frederick John Livesey
Former positions of Frederick John Livesey
Companies | Position | Start | End |
---|---|---|---|
Gen2 Neuroscience Ltd.
![]() Gen2 Neuroscience Ltd. Pharmaceuticals: GenericHealth Technology Gen2 Neuroscience Ltd. develops novel treatments for dementia targeting abnormal forms of the essential cellular protein tau. The company was founded by Frederick John Livesey in January 07, 2016 and is headquartered in Manchester, the United Kingdom. | Chief Executive Officer | 07/01/2016 | - |
Founder | 07/01/2016 | - |
Statistics
International
United Kingdom | 3 |
Operational
Founder | 2 |
Chief Executive Officer | 1 |
Director/Board Member | 1 |
Sectoral
Health Technology | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 2 |
---|---|
Gen2 Neuroscience Ltd.
![]() Gen2 Neuroscience Ltd. Pharmaceuticals: GenericHealth Technology Gen2 Neuroscience Ltd. develops novel treatments for dementia targeting abnormal forms of the essential cellular protein tau. The company was founded by Frederick John Livesey in January 07, 2016 and is headquartered in Manchester, the United Kingdom. | Health Technology |
Talisman Therapeutics Ltd.
![]() Talisman Therapeutics Ltd. BiotechnologyHealth Technology Talisman Therapeutics Ltd. is a human stem cell research and development company. The firm is committed for revolutionizing the discovery of treatments for Alzheimer’s disease. The company is headquartered in Cambridge, the United Kingdom. | Health Technology |